Elise M. Kang, MD
About Elise M. Kang, MD:
Dr. Elise Kang is an Assistant Professor of Pediatrics in the Division of Gastroenterology, Hepatology and Nutrition at Columbia University Irving Medical Center and an Attending Pediatrician at NewYork-Presbyterian Morgan Stanley Children's Hospital.
She holds a BA in psychology from Harvard University and an MD from Case Western Reserve University School of Medicine. She completed her residency in Pediatrics and fellowships in Pediatric Gastroenterology and Advanced Transplant Hepatology at NewYork-Presbyterian Columbia University Medical Center. During her fellowship, she pursued formal training in clinical research and completed a Master’s of Science degree in Patient Oriented Research.
Her areas of clinical expertise include management of children with liver diseases such as neonatal cholestasis, biliary atresia, metabolic conditions, autoimmune liver disease, acute liver failure, and liver transplantation. She performs various procedures including percutaneous liver biopsy, endoscopy, variceal band ligation, and colonoscopy.
Dr. Kang's research focuses on pediatric liver tumors and early post-transplant complications. She has authored several papers on infections and vascular thromboses after transplant and use of checkpoint inhibitors in transplant recipients with liver tumors. She is deeply committed to advancing the care of children with liver disease and aims to partner closely with patients and their families to provide comprehensive care.
Expertise:
Honors:
"Poster of Distinction" - American Association of the Study of Liver Diseases, The Liver Meeting 2020
Honors with Distinction in Research - Case Western Reserve University, 2018
Harvard College Research Program Summer Fellowship - Examined implicit memory in children at the Laboratories of Cognitive Neuroscience at Boston Children’s Hospital, 2011
Education:
New Patients:
Locations
Primary Locations:
CUIMC/NewYork-Presbyterian Morgan Stanley Children's Hospital
3959 Broadway
New York, NY 10032
- For new and current patient appointments, call:
- 212-305-3000
Insurances:
Please contact the doctor's office directly to verify that your particular insurance is accepted.
Publications:
Kang E, Alcamo AM, Maue DK, Beltramo F, Jeyapalan A, Nares M, Monde A, Ridall L, Kamath S, Rowan CM, Mangus RS, Kaushik S, Zinter MS, Resch J, Betters K, Sue PK, and Martinez M. “Postoperative Infectiosn and Antimicrobial Prophylaxis in the Pediatric Intensive Care Unit After Liver Transplantation in Children.” Pediatric Transplantation. 2025 Sept;29(6):e70158.
Moeckli B, Wassmer CH, El Hajji S, Kumar R, Rodrigues Ribeiro J, Tabrizian P, Feng H, Schnickel G, Kulkarni AV, Allaire M, Asthana S, Karvellas CJ, Meeberg G, Wei L, Chouik Y, Kumar P, Gartrell RD, Martinez M, Kang E, Sogbe M, Sangro B, Schwacha-Eipper B, Schmiderer A, Krendl FJ, Goossens N, Lacotte S, Campagnon P, and Tosco C. “Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study.” Hepatology. 2025 Mar 5.
Rezaee-Zavareh MS, Yeo YH, Wang T, Guo Z, Tabrizian P, Ward SC, Barakat F, Hassanein TI, Shravan D, Veeral A, Bhoori S, Mazzaferro V, Chasca DM, Liu MC, Aby ES, Lake JR, Sogbe M, Sangro B, Abdelrahim M, Esmail A, Schmiderer A, Chouik Y, Rudolph M, Sohal D, Giudicelli H, Allaire M, Akce M, Guadagno J, Tow CY, Massoumi H, De Simone P, Kang E, Gartrell RD, Martinez M, Paz-Fumagalli R, Toskich BB, Tran NH, Solino GA, Pacheco DM, Kalman RS, Agopian VG, Mehta N, Parikh ND, Singal A, and Yang JD. “Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis. Journal of Hepatology. 2024 Jul 10
Martinez M*, Kang E*, Beltramo F, Nares M, Jeyapalan A, Alcamo A, Monde A, Ridall L, Kamath S, Betters K, Rowan C, Mangus RS, Kaushik S, Zinter M, Resch J, and Maue E. “Vascular thrombosis after pediatric liver transplantation: Is prevention achievable?” Journal of Liver Transplantation. 2023 Nov 12. (Co-first author)
Maue DK, Martinez M, Alcamo A, Beltramo F, Betters K, Nares M, Jeyapalan A, Zinter M, Kamath S, Ridall S, Monde A, Resch J, Kaushik S, Kang E, Mangus RS, Pike F, and Rowan CM. “Critical Care and Mechanical Ventilation Practices Surrounding Liver Transplantation in Children: A Multicenter Collaborative.” Pediatric Critical Care Medicine. 2022 Oct;24(2): 102-111.
Kang E, Shin JI, Griesemer AD, Lobritto S, Goldner D, Vittorio JM, Stylianos S, and Martinez M. "Risk Factors for 30-Day Unplanned Readmission After Hepatectomy: Analysis of 438 Pediatric Patients from the ACS-NSQIP-P Database." Journal of Gastrointestinal Surgery. 2021 Apr; 25(11): 2851-2858.
Darrow CJ, Bai-Tong SS, Kang EM, Thompason CL, and Walsh MC. “Use of acidified versus non-acidified liquid human milk fortifier in very low birth weight infants: A retrospective comparison of clinical outcomes.” Journal of Neonatal Perinatal Medicine. 2020;13(1):71-79.
Ciolek PJ, Kang E, Honaker JA, Woodson EA, Hopkins BS, and Anne S. “Pediatric vestibular testing: Tolerability of test components in children.” International Journal of Pediatric Otorhinolaryngology. 2018 Oct;113:29-33.
Kerr R, Kang E, Hopkins B, and Anne S. “Pediatric Tinnitus: Incidence of Imaging Anomalies and the Impact of Hearing Loss.” International Journal of Pediatric Otorhinolaryngology. 2017 Dec;103:147-149.
Kang E, Martinez M, George D, Brejt SZ, Lee M, Yamashiro DJ, Cantor A, Kapoor U, Lobritto S, Weintraub J, and Spector PR. “Novel Treatment of Yttrium-90 Radioembolization-Induced Liver Disease with Defibrotide in a Pediatric Liver Transplant Recipient.” Pediatric Blood and Cancer. 2025 Nov;72(11):e31974.
Kang E, Martinez M, Moisander-Joyce H, Saenger YM, Griesemer A, Kato T, Yamashiro DJ, Remotti H, and Gartrell RD. "Stable liver graft post anti-PD1 therapy as a bridge to transplantation in an adolescent with hepatocellular carcinoma." Pediatric Transplantation. 2021 May;26(3): e14209.
Kang E, Khalili A, Splawski J, Sferra TJ, and Moses J. “Reversal of Immunogenicity in Pediatric Inflammatory Bowel Disease Patients Receiving Anti-TNF Medications.” Pediatric Gastroenterology, Hepatology, and Nutrition. 2018 Oct;21(4):329-335.
Kang E, Friedman N, Mamoun I, Tamburro J, and Golden A. Beta Blockade as Treatment for Intracranial Infantile Hemangioma: Case Report and Literature Review. Pediatric Neurology. 2016; 59:13-17.
Mencin A and Kang E. “Normal Structure and Function of the Gastrointestinal Tract.” Pediatrics, 24th Edition.
Martinez M and Kang E. “Autoimmune Hepatitis.” The 5-Minute Pediatric Consult, 9th Edition.
Martinez M and Kang E. “Primary Sclerosing Cholangitis.” The 5-Minute Pediatric Consult, 9th Edition.
Kang E, Liou P, and Martinez M. “A Call to Action: Furthering the Utilization of Technical Variants Pediatric Liver Transplantation Through Increased Awareness and Education.” Transplantation. 2023 Aug.
Kang E, Lobritto S, Martinez M. “Weighing in on organ allocation for tweens.” Liver Transplantation. 2023 Nov 28.